HAYDEN JEREMY B. 4

What Happened Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, was granted 115,920 restricted stock units (RSUs) on February 3, 2026. The Form 4 reports an acquisition price of $0.00 (typical for compensation awards); the grant size was set at $750,000 divided by the closing stock price on the grant date. Each RSU represents a contingent right to one share of common stock upon vesting.

Key Details

• Transaction date and price: Grant dated 2026-02-03; acquisition price reported as $0.00; grant value $750,000 (per footnote calculation).
• Vesting: RSUs vest in 16 equal quarterly installments beginning March 31, 2026 and continuing through December 31, 2029, subject to continued service.
• Shares owned after transaction: 75,562 shares of common stock owned outright and 307,969 shares that will be acquired upon vesting of unvested RSUs (total beneficial interest noted = 383,531, per footnote).
• Footnotes: F1 describes the RSU grant and vesting schedule; F2 reports the breakdown of currently owned shares and unvested RSUs.
• Filing timeliness: Report covers 2026-02-03 and was filed 2026-02-05, consistent with standard Section 16 reporting timelines.

Context This was a compensation award (RSUs), not an open-market purchase or sale. RSUs are contingent on continued service and convert to shares as they vest; they do not represent an immediate cash transaction or sale. Such grants are common executive compensation and should be viewed as part of pay structure rather than a direct bullish or bearish trading signal.